La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Align Technology a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Align Technology..

Align Technology (NASDAQ:ALGN) Azioni, Catena delle Opzioni

ALIGN TECHNOLOGY INC

Align Technology

Align Tech

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Align Technology Inc

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Align Technology, Inc. - ALGN

News

Legal

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Align Technology, Inc. – ALGN

ALIGN ALERT: Bragar Eagel & Squire, P.C. is Investigating Align Technology, Inc. on Behalf of Align Stockholders and Encourages Investors to Contact the Firm

Align Technology Files ITC Complaint to Block Unlawful Imports of Clear Aligners From Angelalign Technology

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Align Technology, Inc. – ALGN

Align Technology Advances Digital Orthodontics With Invisalign® Through Best-in-Class Clinical Education and Peer-to-Peer Learning at Its Global Faculty Meeting of Doctor Educators

ALIGN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Align Technology, Inc. on Behalf of Align Stockholders and Encourages Investors to Contact the Firm

Align Technology to Announce Third Quarter 2025 Results on October 29, 2025

ALGN

Alcon

Avanos Medical

Bausch & Lomb

Bioventus

Cerus

The Cooper Companies, Inc. - Common Stock

Cooper Companies

Embecta

Establishment Labs Holdings Inc. - Common Shares

Establishment Labs Hldgs

Haemonetics

ICU Medical

OrthoPediatrics

Lantheus Holdings

Merit Medical Systems, Inc. - Common Stock

Merit Medical Systems

Neogen

InspireMD

OraSure Technologies, Inc. - Common Stock

OraSure Technologies

RxSight

Sanara MedTech

Solventum

Staar Surgical

Sharps Technology

UFP Technologies

Utah Medical Products, Inc. - Common Stock

Utah Medical Products

Dentsply Sirona

Xtant Medical Holdings, Inc. Common Stock

Xtant Medical Hldgs

Stifel

Wells Fargo

Piper Sandler

Morgan Stanley

Evercore ISI Group

Comments

Align Technology

Align Technology (ALGN) Opzioni

Align Technology (NASDAQ:ALGN) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO